13F filer · CIK 1776382
venBio Partners LLC
SAN FRANCISCO, CA · filing since Q4 2018 · last filing Aug 14, 2026
Reported value
$519.4M
+$238.8M vs prior
Positions
7
New / sold out
2 / 1
Added / reduced
1 / 1
Turnover
1.0%
buys $182.9M · sells $4.0M
Top-10 weight
100.0%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | PARABILIS MEDICINES INC | +5,266,697 | – | +$144.1M |
| New | ACHIEVE LIFE SCIENCE INC | +5,914,720 | – | +$38.6M |
| Added | PHARVARIS N V | +4,126 | +0.1% | +$142.7K |
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | ARTIVA BIOTHERAPEUTICS INC | -531,337 | -100.0% | $-3.4M |
| Reduced | HARMONY BIOSCIENCES HLDGS IN | -17,000 | -3.5% | $-619.0K |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | PHARVARIS N VCOM | 4,643,430 | $160.6M | 30.92% |
| 2 | PARABILIS MEDICINES INCCOM | 5,266,697 | $144.1M | 27.75% |
| 3 | ALUMIS INCCOM | 4,528,408 | $127.4M | 24.53% |
| 4 | ACHIEVE LIFE SCIENCE INCCOM | 5,914,720 | $38.6M | 7.44% |
| 5 | ALX ONCOLOGY HLDGS INCCOM | 12,884,638 | $26.7M | 5.14% |
| 6 | HARMONY BIOSCIENCES HLDGS INCOM | 472,194 | $17.2M | 3.31% |
| 7 | LYELL IMMUNOPHARMA INCCOM NEW | 337,697 | $4.7M | 0.91% |